|
VDAC2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.393420E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.186950E-04 |
| Normal-vs-Stage2 |
3.506000E-02 |
| Normal-vs-Stage3 |
1.371890E-02 |
| Normal-vs-Stage4 |
3.495600E-01 |
| Stage1-vs-Stage2 |
8.588800E-01 |
| Stage1-vs-Stage3 |
7.790600E-01 |
| Stage1-vs-Stage4 |
1.977780E-03 |
| Stage2-vs-Stage3 |
9.587400E-01 |
| Stage2-vs-Stage4 |
2.811800E-02 |
| Stage3-vs-Stage4 |
1.694360E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.181510E-04 |
| Normal-vs-AfricanAmerican |
5.466000E-02 |
| Normal-vs-Asian |
7.141000E-01 |
| Caucasian-vs-AfricanAmerican |
2.365800E-01 |
| Caucasian-vs-Asian |
7.199800E-01 |
| AfricanAmerican-vs-Asian |
8.720400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.05669999999714E-05 |
| Normal-vs-Female |
6.978400E-02 |
| Male-vs-Female |
1.126070E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.245710E-02 |
| Normal-vs-Extreme_Weight |
4.587900E-04 |
| Normal-vs-Obese |
9.395300E-03 |
| Normal-vs-Extreme_Obese |
4.113600E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.395800E-01 |
| Normal_Weight-vs-Obese |
9.573800E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.163400E-01 |
| Extreme_Weight-vs-Obese |
4.928200E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.634600E-01 |
| Obese-vs-Extreme_Obese |
9.321800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.003600E-01 |
| Normal-vs-Age(41-60Yrs) |
5.64140000000046E-05 |
| Normal-vs-Age(61-80Yrs) |
2.164900E-03 |
| Normal-vs-Age(81-100Yrs) |
2.718800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.761800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.205000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.231400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.675390E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.392800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.299000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
4.02940000000518E-05 |
| Normal-VS-Type2 PRCC |
4.472500E-02 |
| Normal-VS-KIRP CIMP |
9.525400E-01 |
| Normal-VS-Unclassified PRCC |
9.983900E-04 |
| Type1 PRCC-VS-Type2 PRCC |
2.461900E-02 |
| Type1 PRCC-VS-KIRP CIMP |
2.152400E-02 |
| Type1 PRCC-VS-Unclassified PRCC |
5.172400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.673400E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
1.984230E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.184400E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
6.394700E-04 |
| Normal-vs-N1 |
4.337200E-01 |
| Normal-vs-N2 |
2.065800E-01 |
| N0-vs-N1 |
1.664770E-01 |
| N0-vs-N2 |
7.431000E-01 |
| N1-vs-N2 |
6.941000E-01 |
|
|
